378 related articles for article (PubMed ID: 30580088)
21. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release.
Scheeren LE; Nogueira DR; Macedo LB; Vinardell MP; Mitjans M; Infante MR; Rolim CM
Colloids Surf B Biointerfaces; 2016 Feb; 138():117-27. PubMed ID: 26674840
[TBL] [Abstract][Full Text] [Related]
22. Platinated graphene oxide: A nanoplatform for efficient gene-chemo combination cancer therapy.
Liu P; Wang S; Liu X; Ding J; Zhou W
Eur J Pharm Sci; 2018 Aug; 121():319-329. PubMed ID: 29906508
[TBL] [Abstract][Full Text] [Related]
23. The interaction of dendrimer-doxorubicin conjugates with a model pulmonary epithelium and their cosolvent-free, pseudo-solution formulations in pressurized metered-dose inhalers.
Zhong Q; Humia BV; Punjabi AR; Padilha FF; da Rocha SRP
Eur J Pharm Sci; 2017 Nov; 109():86-95. PubMed ID: 28774811
[TBL] [Abstract][Full Text] [Related]
24. A tumor-targeting near-infrared laser-triggered drug delivery system based on GO@Ag nanoparticles for chemo-photothermal therapy and X-ray imaging.
Shi J; Wang L; Zhang J; Ma R; Gao J; Liu Y; Zhang C; Zhang Z
Biomaterials; 2014 Jul; 35(22):5847-61. PubMed ID: 24746963
[TBL] [Abstract][Full Text] [Related]
25. Multi-functional nanocarriers based on iron oxide nanoparticles conjugated with doxorubicin, poly(ethylene glycol) and folic acid as theranostics for cancer therapy.
Rajkumar S; Prabaharan M
Colloids Surf B Biointerfaces; 2018 Oct; 170():529-537. PubMed ID: 29966906
[TBL] [Abstract][Full Text] [Related]
26. Biocompatible graphene oxide nanoparticle-based drug delivery platform for tumor microenvironment-responsive triggered release of doxorubicin.
Zhao X; Liu L; Li X; Zeng J; Jia X; Liu P
Langmuir; 2014 Sep; 30(34):10419-29. PubMed ID: 25109617
[TBL] [Abstract][Full Text] [Related]
27. Effect of Chemical Binding of Doxorubicin Hydrochloride to Gold Nanoparticles, Versus Electrostatic Adsorption, on the In Vitro Drug Release and Cytotoxicity to Breast Cancer Cells.
Zayed GM; Kamal I; Abdelhafez WA; M Alsharif F; Amin MA; Shaykoon MSA; Sarhan HA; Abdelsalam AM
Pharm Res; 2018 Mar; 35(6):112. PubMed ID: 29603025
[TBL] [Abstract][Full Text] [Related]
28. Functionalized graphene oxide nanoparticles for cancer cell-specific delivery of antitumor drug.
Zhao X; Yang L; Li X; Jia X; Liu L; Zeng J; Guo J; Liu P
Bioconjug Chem; 2015 Jan; 26(1):128-36. PubMed ID: 25525819
[TBL] [Abstract][Full Text] [Related]
29. Reduced graphene oxide (rGO) hybridized hydrogel as a near-infrared (NIR)/pH dual-responsive platform for combined chemo-photothermal therapy.
Liu W; Zhang X; Zhou L; Shang L; Su Z
J Colloid Interface Sci; 2019 Feb; 536():160-170. PubMed ID: 30366181
[TBL] [Abstract][Full Text] [Related]
30. Carboxymethyl chitosan-mediated synthesis of hyaluronic acid-targeted graphene oxide for cancer drug delivery.
Yang H; Bremner DH; Tao L; Li H; Hu J; Zhu L
Carbohydr Polym; 2016 Jan; 135():72-8. PubMed ID: 26453853
[TBL] [Abstract][Full Text] [Related]
31. Folic acid-functionalized graphene oxide nanosheets via plasma etching as a platform to combine NIR anticancer phototherapy and targeted drug delivery.
Mauro N; Scialabba C; Agnello S; Cavallaro G; Giammona G
Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110201. PubMed ID: 31761243
[TBL] [Abstract][Full Text] [Related]
32. Graphene oxide used as a carrier for adriamycin can reverse drug resistance in breast cancer cells.
Wu J; Wang YS; Yang XY; Liu YY; Yang JR; Yang R; Zhang N
Nanotechnology; 2012 Sep; 23(35):355101. PubMed ID: 22875697
[TBL] [Abstract][Full Text] [Related]
33. Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation.
Han X; Li Z; Sun J; Luo C; Li L; Liu Y; Du Y; Qiu S; Ai X; Wu C; Lian H; He Z
J Control Release; 2015 Jan; 197():29-40. PubMed ID: 25449802
[TBL] [Abstract][Full Text] [Related]
34. Near-infrared light remote-controlled intracellular anti-cancer drug delivery using thermo/pH sensitive nanovehicle.
Qin Y; Chen J; Bi Y; Xu X; Zhou H; Gao J; Hu Y; Zhao Y; Chai Z
Acta Biomater; 2015 Apr; 17():201-9. PubMed ID: 25644449
[TBL] [Abstract][Full Text] [Related]
35. Multi-stimuli responsive mesoporous carbon nano-platform gated by human serum albumin for cancer thermo-chemotherapy.
Zhao Q; Wang X; Yang M; Li X; Mao Y; Guan X; Di D; Wang S
Colloids Surf B Biointerfaces; 2019 Dec; 184():110532. PubMed ID: 31590051
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of a novel thermo/pH sensitive nanogel based on salep modified graphene oxide for drug release.
Bardajee GR; Hooshyar Z; Farsi M; Mobini A; Sang G
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():558-565. PubMed ID: 28024622
[TBL] [Abstract][Full Text] [Related]
37. Preparation of a multifunctional verapamil-loaded nano-carrier based on a self-assembling PEGylated prodrug.
Zhao D; Liu N; Shi K; Wang X; Wu G
Colloids Surf B Biointerfaces; 2015 Nov; 135():682-688. PubMed ID: 26340357
[TBL] [Abstract][Full Text] [Related]
38. Heparin modified graphene oxide for pH-sensitive sustained release of doxorubicin hydrochloride.
Zhang B; Yang X; Wang Y; Zhai G
Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():198-206. PubMed ID: 28415455
[TBL] [Abstract][Full Text] [Related]
39. Bile Acid-Based Drug Delivery Systems for Enhanced Doxorubicin Encapsulation: Comparing Hydrophobic and Ionic Interactions in Drug Loading and Release.
Cunningham AJ; Robinson M; Banquy X; Leblond J; Zhu XX
Mol Pharm; 2018 Mar; 15(3):1266-1276. PubMed ID: 29378128
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and in vitro evaluation of pH-sensitive PEG-I-dC16 block polymer micelles for anticancer drug delivery.
Rongbin H; Lei X; Ying L; Xiangping D; Xuan C; Lanfang L; Cuiyun Y; Yanming C; Guotao T
J Pharm Pharmacol; 2016 Jun; 68(6):751-61. PubMed ID: 27018539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
